{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:08:56Z","timestamp":1766869736775},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02311-x","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:02:37Z","timestamp":1710288157000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["High expression of CD9 and Epidermal Growth Factor Receptor promotes the development of tongue cancer"],"prefix":"10.1007","volume":"41","author":[{"given":"P. C.","family":"Suhasini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadisha","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa S","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen Kumar","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. G.","family":"Roopashree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Suchetha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"issue":"1","key":"2311_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/cncr.26229","volume":"118","author":"I Ganly","year":"2012","unstructured":"Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue-clinicopathologic features affecting outcome. Cancer. 2012;118(1):101\u201311.","journal-title":"Cancer"},{"key":"2311_CR2","doi-asserted-by":"crossref","unstructured":"Campbell BR, Netterville JL, Sinard RJ, Mannion K, Rohde SL, Langerman A, et al. Early onset oral tongue cancer in the United States: a literature review. Oral Oncol [Internet]. 2018 Dec 1 [cited 2023 Oct 30]; 87:1. Available from: \/pmc\/articles\/PMC7039330\/","DOI":"10.1016\/j.oraloncology.2018.10.009"},{"issue":"3","key":"2311_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5794\/jjoms.59.159","volume":"59","author":"Y Zushi","year":"2013","unstructured":"Zushi Y, Noguchi K, Urade M. An in vitro multistep carcinogenesis model for both HPV-positive and -negative human oral squamous cell carcinomas. Japanese J Oral Maxillofac Surg. 2013;59(3):159\u201371.","journal-title":"Japanese J Oral Maxillofac Surg"},{"issue":"2","key":"2311_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1601-0825.2006.01349.x","volume":"13","author":"SK Mithani","year":"2007","unstructured":"Mithani SK, Mydlarz WK, Grumbine FL, Smith IM, Califano JA. Molecular genetics of premalignant oral lesions. Oral Dis. 2007;13(2):126\u201333.","journal-title":"Oral Dis"},{"key":"2311_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.oraloncology.2017.02.019","volume":"67","author":"JE Tota","year":"2017","unstructured":"Tota JE, Anderson WF, Coffey C, Califano J, Cozen W, Ferris RL, et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973\u20132012. Oral Oncol. 2017;67:146\u201352. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.02.019.","journal-title":"Oral Oncol"},{"issue":"2","key":"2311_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yexmp.2003.10.005","volume":"76","author":"KM Mohamed","year":"2004","unstructured":"Mohamed KM, Le A, Duong H, Wu Y, Zhang Q, Messadi DV. Correlation between VEGF and HIF-1\u03b1 expression in human oral squamous cell carcinoma. Exp Mol Pathol. 2004;76(2):143\u201352.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"2311_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.radonc.2012.01.011","volume":"103","author":"CM Hoff","year":"2012","unstructured":"Hoff CM, Grau C, Overgaard J. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma - a prospective study. Radiother Oncol. 2012;103(1):38\u201344. https:\/\/doi.org\/10.1016\/j.radonc.2012.01.011.","journal-title":"Radiother Oncol"},{"key":"2311_CR8","doi-asserted-by":"crossref","unstructured":"Rouger-Gaudichon J, Cousin E, Jakobczyk H, Debaize L, Rio AG, Forestier A, et al. Hypoxia regulates CD9 expression and dissemination of B lymphoblasts. Leuk Res [Internet]. 2022 Dec 1 [cited 2023 Oct 30] 123. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36335655\/","DOI":"10.1016\/j.leukres.2022.106964"},{"key":"2311_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1399-0039.2004.00321.x","volume":"64","author":"MD Wright","year":"2004","unstructured":"Wright MD, Moseley GW, van Spriel AB. Tetraspanin microdomains in immune cell signalling and malignant disease. Tissue Antigens. 2004;64:533\u201342.","journal-title":"Tissue Antigens"},{"key":"2311_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nrd2659","volume":"7","author":"ME Hemler","year":"2008","unstructured":"Hemler ME. Targeting of tetraspanin proteins-potential benefits and strategies. Nat Rev Drug Discov. 2008;7:747\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"2311_CR11","unstructured":"H T Maecker1, S C Todd SL. The tetraspanin superfamily: molecular facilitators - PubMed. [cited 2023 Oct 30]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9194523\/"},{"issue":"8","key":"2311_CR12","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1158\/1078-0432.CCR-06-1692","volume":"13","author":"JC Wang","year":"2007","unstructured":"Wang JC, B\u00e9gin LR, B\u00e9rub\u00e9 NG, Chevalier S, Aprikian AG, Gourdeau H, et al. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Clin Cancer Res. 2007;13(8):2354\u201361.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2311_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3892\/or.2015.3960","volume":"34","author":"M Tang","year":"2015","unstructured":"Tang M, Yin G, Wang F, Liu H, Zhou S, Ni J, et al. Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface. Oncol Rep. 2015;34(1):350\u20138.","journal-title":"Oncol Rep"},{"issue":"12","key":"2311_CR14","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1158\/1078-0432.CCR-03-0249","volume":"10","author":"P Amornphimoltham","year":"2004","unstructured":"Amornphimoltham P, Sriuranpong V, Patel V, Benavides F, Conti CJ, Sauk J, et al. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res. 2004;10(12):4029\u201337.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2311_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"9","key":"2311_CR16","doi-asserted-by":"publisher","first-page":"e10699","DOI":"10.1371\/journal.pone.0106999","volume":"9","author":"MJ Herr","year":"2014","unstructured":"Herr MJ, Mabry SE, Jennings LK. Tetraspanin CD9 regulates cell contraction and actin arrangement via RhoA in human vascular smooth muscle cells. PLoS ONE. 2014;9(9):e10699.","journal-title":"PLoS ONE"},{"issue":"4","key":"2311_CR17","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.3892\/mmr.2016.4951","volume":"13","author":"T Nagaoka","year":"2016","unstructured":"Nagaoka T, Kitaura K, Miyata Y, Kumagai K, Kaneda G, Kanazawa H, et al. Downregulation of epidermal growth factor receptor family receptors and ligands in a mutant K-ras group of patients with colorectal cancer. Mol Med Rep. 2016;13(4):3514\u201320.","journal-title":"Mol Med Rep"},{"issue":"3","key":"2311_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3892\/ol.2013.1132","volume":"5","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhang LL, Shen L, Xu XM, Yu HG. Regulation of AKT gene expression by cisplatin. Oncol Lett. 2013;5(3):756\u201360.","journal-title":"Oncol Lett"},{"issue":"2","key":"2311_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5455\/jabet.2021.d120","volume":"4","author":"AB Manjappa","year":"2021","unstructured":"Manjappa AB, Rao S, Shetty S, Shetty V, Asode AS, Molahalli SS, et al. Characterization of human articular cartilage derived mesenchymal progenitor cells from osteoarthritis patients. J Adv Biotechnol Exp Ther. 2021;4(2):200\u20139.","journal-title":"J Adv Biotechnol Exp Ther."},{"key":"2311_CR20","unstructured":"Lin Li, Shao-Hua Chen, Yu Zhang, Chao-Hui Yu, Shu-Dan Li YML. Is the hypoxia-inducible factor-1 alpha mRNA expression activated by ethanol-induced injury, the mechanism underlying alcoholic liver disease? - PubMed [Internet]. [cited 2023 Oct 30]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17085342\/"},{"issue":"9","key":"2311_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1096\/fj.02-0172fje","volume":"17","author":"SE Michaud","year":"2003","unstructured":"Michaud SE, M\u00e9nard C, Guy LG, Gennaro G, Rivard A. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha\/VEGF pathway. FASEB J. 2003;17(9):1150\u20132.","journal-title":"FASEB J"},{"issue":"1","key":"2311_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1600-0714.2007.00571.x","volume":"37","author":"PY Lin","year":"2008","unstructured":"Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, Kuo MYP, et al. Expression of hypoxia-inducible factor-1\u03b1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 2008;37(1):18\u201325.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"2311_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.flm.2017.08.001","volume":"1","author":"L Jiang","year":"2017","unstructured":"Jiang L, Hochwald S, Deng S, Zhu Y, Tan C, Zhong Q, et al. Evaluation of EGF, EGFR, and E-cadherin as potential biomarkers for gastrointestinal cancers. Front Lab Med. 2017;1(3):135\u201340. https:\/\/doi.org\/10.1016\/j.flm.2017.08.001.","journal-title":"Front Lab Med."},{"issue":"3\u20134","key":"2311_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2478\/folmed-2013-0024","volume":"55","author":"C Tsalikidis","year":"2013","unstructured":"Tsalikidis C, Papachristou F, Pitiakoudis M, Asimakopoulos B, Trypsianis G, Bolanaki E, et al. Soluble E-cadherin as a diagnostic and prognostic marker in gastric carcinoma. Folia Med (Plovdiv). 2013;55(3\u20134):26\u201332.","journal-title":"Folia Med (Plovdiv)"},{"issue":"1","key":"2311_CR25","first-page":"139","volume":"176","author":"GH Shernan","year":"2016","unstructured":"Shernan GH, Michael RV, Kirk RS, Laura FN, Gabrielle M, Fiona H, Todd ED, Gregory MV, Arne S, Margaret LM, Sarah AC, Bruce RB, Angela P-M, and,. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease. Biol Blood Marrow Transplant. 2016;176(1):139\u201348.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2311_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/ijms17040593","volume":"17","author":"S Maramotti","year":"2016","unstructured":"Maramotti S, Paci M, Manzotti G, Rapicetta C, Gugnoni M, Galeone C, et al. Soluble epidermal growth factor receptors (sEGFRs) in cancer: Biological aspects and clinical relevance. Int J Mol Sci. 2016;17(4):593.","journal-title":"Int J Mol Sci"},{"key":"2311_CR27","unstructured":"Heng H, Lingling G, Cun W, Yan L, Huiying M, Long C, Jie Q, Binbin L, Yinkun LCL. Lower serum soluble-EGFR is a potential biomarker for metastasis of HCC demonstrated by N-glycoproteomic analysis - PubMed [Internet]. [cited 2023 Oct 30]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26105696\/"},{"issue":"9\u201310","key":"2311_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.lfs.2011.06.020","volume":"89","author":"KA Adamczyk","year":"2011","unstructured":"Adamczyk KA, Klein-Scory S, Tehrani MM, Warnken U, Schmiegel W, Schn\u00f6lzer M, et al. Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells. Life Sci. 2011;89(9\u201310):304\u201312. https:\/\/doi.org\/10.1016\/j.lfs.2011.06.020.","journal-title":"Life Sci"},{"key":"2311_CR29","first-page":"2270","volume":"5","author":"B Singh","year":"2016","unstructured":"Singh B, Carpenter G, Coffey RJ. EGF receptor ligands: recent advances. Research. 2016;5:2270.","journal-title":"Research"},{"key":"2311_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1210\/edrv-11-3-418","volume":"11","author":"DA Fisher","year":"1990","unstructured":"Fisher DA, Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev. 1990;11:418\u201342.","journal-title":"Endocr Rev"},{"issue":"5","key":"2311_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052.PMID:28513565;PMCID:PMC5447962","volume":"9","author":"P Wee","year":"2017","unstructured":"Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). 2017;9(5):52. https:\/\/doi.org\/10.3390\/cancers9050052.PMID:28513565;PMCID:PMC5447962.","journal-title":"Cancers (Basel)"},{"key":"2311_CR32","doi-asserted-by":"publisher","first-page":"10761","DOI":"10.3390\/ijms140610761","volume":"14","author":"K-I Sato","year":"2013","unstructured":"Sato K-I. Cellular functions regulated by phosphorylation of EGFR on Tyr845. Int J Mol Sci. 2013;14:10761\u201390.","journal-title":"Int J Mol Sci"},{"key":"2311_CR33","first-page":"a011254","volume":"4","author":"DK Morrison","year":"2012","unstructured":"Morrison DK. MAP kinase pathways. Perspect Biol. 2012;4:a011254.","journal-title":"Perspect Biol"},{"key":"2311_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","volume":"74","author":"TS Lewis","year":"1998","unstructured":"Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998;74:49\u2013139.","journal-title":"Adv Cancer Res"},{"key":"2311_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","volume":"25","author":"CC Dibble","year":"2015","unstructured":"Dibble CC, Cantley LC. Regulation of mTORC1 by PI3K signaling. Trends Cell Biol. 2015;25:545\u201355.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"2311_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170(4):605\u201335.","journal-title":"Cell"},{"issue":"1","key":"2311_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1182\/blood-2005-03-1312","volume":"107","author":"JC Qi","year":"2006","unstructured":"Qi JC, Wang J, Mandadi S, Tanaka K, Roufogalis BD, Madigan MC, et al. Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood. 2006;107(1):135\u201342.","journal-title":"Blood"},{"issue":"8","key":"2311_CR38","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.yexcr.2008.01.024","volume":"314","author":"J Kotha","year":"2008","unstructured":"Kotha J, Longhurst C, Appling W, Jennings LK. Tetraspanin CD9 regulates \u03b21 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway. Exp Cell Res. 2008;314(8):1811\u201322.","journal-title":"Exp Cell Res"},{"issue":"10","key":"2311_CR39","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.18632\/oncotarget.3419","volume":"6","author":"G Rappa","year":"2015","unstructured":"Rappa G, Green TM, Karbanov\u00e1 J, Corbeil D, Lorico A. Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget. 2015;6(10):7970\u201391.","journal-title":"Oncotarget"},{"issue":"3","key":"2311_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1083\/jcb.141.3.791","volume":"141","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"1998","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Alfranca A, Caba\u00f1as C, Marazuela M, Tejedor R, Ursa MA, et al. Regulation of endothelial cell motility by complexes of retraspan molecules CD81\/TAPA-1 and CD151\/PETA-3 with \u03b13\u03b21 integrin localized at endothelial lateral junctions. J Cell Biol. 1998;141(3):791\u2013804.","journal-title":"J Cell Biol"},{"issue":"6","key":"2311_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1365-2133.1997.tb01544.x","volume":"137","author":"H Okochi","year":"1997","unstructured":"Okochi H, Kato M, Nashiro K, Yoshie O, Miyazono K, Furue M. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with \u03b13\u03b21 integrin. Br J Dermatol. 1997;137(6):856\u201363.","journal-title":"Br J Dermatol"},{"issue":"5","key":"2311_CR42","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1083\/jcb.128.5.929","volume":"128","author":"S Higashiyama","year":"1995","unstructured":"Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, et al. The membrane protein CD9\/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol. 1995;128(5):929\u201338.","journal-title":"J Cell Biol"},{"issue":"4","key":"2311_CR43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/cre2.293","volume":"6","author":"M Noi","year":"2020","unstructured":"Noi M, Ichi MK, Murakami S, Koshinuma S, Machida Y, Yamori M, et al. Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival. Clin Exp Dent Res. 2020;6(4):420\u20137.","journal-title":"Clin Exp Dent Res."},{"issue":"1","key":"2311_CR44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.18632\/oncotarget.5477","volume":"7","author":"N Podergajs","year":"2023","unstructured":"Podergajs N, Motaln H, Raj\u010devi\u0107 U, Verbov\u0161ek U, Kor\u0161i\u010d M, Obad N, et al. Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells. Oncotarget. 2023;7(1):593\u2013609.","journal-title":"Oncotarget"},{"issue":"11","key":"2311_CR45","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.3748\/wjg.v21.i11.3206","volume":"21","author":"Y Murayama","year":"2015","unstructured":"Murayama Y, Oritani K, Tsutsui S. Novel CD9-targeted therapies in gastric cancer. World J Gastroenterol. 2015;21(11):3206\u201313.","journal-title":"World J Gastroenterol"},{"issue":"40","key":"2311_CR46","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.18632\/oncotarget.27021","volume":"10","author":"M Ullah","year":"2019","unstructured":"Ullah M, Akbar A, Thakor AS. An emerging role of CD9 in stemness and chemoresistance. Oncotarget. 2019;10(40):4000\u20131.","journal-title":"Oncotarget"},{"key":"2311_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00863","volume":"9","author":"R Reyes","year":"2018","unstructured":"Reyes R, Carde\u00f1es B, Machado-Pineda Y, Caba\u00f1as C. Tetraspanin CD9: a key regulator of cell adhesion in the immune system. Front Immunol. 2018;9:1\u20139.","journal-title":"Front Immunol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02311-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02311-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02311-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T09:17:39Z","timestamp":1711617459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02311-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["2311"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02311-x","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"26 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of NITTE (Deemed to be University) (Ref. NU\/CEC\/2020\/0336). Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"86"}}